STANNOUS FLUORIDE RINSE

STANNOUS FLUORIDE RINSE was reported 43 times

STANNOUS FLUORIDE RINSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINARY SEDIMENT 1 0.0172
1 FACIAL OPERATION 1 0.0062
2 INCREASED NEED FOR SLEEP 1 0.0043
3 PSEUDOSTROKE 1 0.0029
4 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
5 IMMUNOGLOBULINS INCREASED 1 0.0021
6 NAIL GROWTH ABNORMAL 1 0.0009
7 NEUROENDOCRINE TUMOUR 1 0.0007
8 SHOULDER FRACTURE 1 0.0006
9 GASTRIC DILATATION 1 0.0006
10 HISTOPLASMOSIS 1 0.0006
11 HYPOGEUSIA 1 0.0005
12 FAECES PALE 1 0.0004
13 STEATORRHOEA 1 0.0004
14 LIP PAIN 1 0.0003
15 NEURODERMATITIS 1 0.0003
16 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
17 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
18 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
19 GASTROINTESTINAL PAIN 2 0.0002
20 BLOOD URIC ACID INCREASED 1 0.0002
21 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
22 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
23 HYDRONEPHROSIS 1 0.0001
24 BLOOD CALCIUM INCREASED 1 0.0001
25 PNEUMONIA BACTERIAL 1 0.0001
26 IRON DEFICIENCY ANAEMIA 1 0.0001
27 PRODUCT DISTRIBUTION ISSUE 1 0.0001
28 THERAPY CHANGE 1 0.0001
29 SPINAL FRACTURE 2 0.0001
30 POOR VENOUS ACCESS 1 0.0001
31 VENTRICULAR EXTRASYSTOLES 1 0.0001
32 TENDERNESS 1 0.0001
33 RENAL PAIN 1 0.0001
34 FOOT DEFORMITY 1 0.0001
35 PARAESTHESIA ORAL 1 0.0001
36 SYRINGE ISSUE 1 0.0001
37 RESTLESS LEGS SYNDROME 1 0.0001
38 INCREASED APPETITE 1 0.0001
39 ERUCTATION 1 0.0001
40 NEPHROLITHIASIS 2 0.0000
41 AGEUSIA 1 0.0000
42 GASTRIC CANCER 1 0.0000
43 RESPIRATORY TRACT INFECTION 1 0.0000
44 EAR INFECTION 1 0.0000
45 PNEUMONITIS 1 0.0000
46 INTENTIONAL DOSE OMISSION 1 0.0000
47 BLOOD POTASSIUM DECREASED 1 0.0000
48 STOMATITIS 2 0.0000
49 CYSTITIS 1 0.0000
50 HYPOTHYROIDISM 1 0.0000
51 FUNGAL INFECTION 1 0.0000
52 THERAPY INTERRUPTED 2 0.0000
53 COLITIS ULCERATIVE 1 0.0000
54 DYSPEPSIA 2 0.0000
55 ABDOMINAL DISTENSION 2 0.0000
56 PANCREATITIS 1 0.0000
57 RASH PRURITIC 1 0.0000
58 DYSPHONIA 1 0.0000
59 NASAL CONGESTION 1 0.0000
60 PNEUMONIA 5 0.0000
61 UNEVALUABLE EVENT 1 0.0000
62 CHRONIC KIDNEY DISEASE 1 0.0000
63 ACUTE KIDNEY INJURY 2 0.0000
64 PERIPHERAL SWELLING 2 0.0000
65 INJECTION SITE HAEMORRHAGE 1 0.0000
66 DRY MOUTH 1 0.0000
67 SKIN EXFOLIATION 1 0.0000
68 DEVICE ISSUE 1 0.0000
69 OROPHARYNGEAL PAIN 1 0.0000
70 CHEST PAIN 2 0.0000
71 CARDIAC DISORDER 1 0.0000
72 NEUROPATHY PERIPHERAL 1 0.0000
73 ATRIAL FIBRILLATION 1 0.0000
74 HAEMOGLOBIN DECREASED 1 0.0000
75 ERYTHEMA 2 0.0000
76 ILLNESS 1 0.0000
77 PLATELET COUNT DECREASED 1 0.0000
78 CONSTIPATION 2 0.0000
79 INFLUENZA 1 0.0000
80 SEPSIS 1 0.0000
81 THROMBOCYTOPENIA 1 0.0000
82 WEIGHT INCREASED 2 0.0000
83 ASTHMA 1 0.0000
84 MUSCULAR WEAKNESS 1 0.0000
85 BACK PAIN 2 0.0000
86 CHILLS 1 0.0000
87 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
88 DEHYDRATION 1 0.0000
89 DRY SKIN 1 0.0000
90 COUGH 2 0.0000
91 INFECTION 1 0.0000
92 HOSPITALISATION 1 0.0000
93 PARAESTHESIA 1 0.0000
94 CONFUSIONAL STATE 1 0.0000
95 TREMOR 1 0.0000
96 DIZZINESS 3 0.0000
97 FALL 2 0.0000
98 ABDOMINAL DISCOMFORT 1 0.0000
99 URINARY TRACT INFECTION 1 0.0000
100 NASOPHARYNGITIS 1 0.0000
101 HYPERSENSITIVITY 1 0.0000
102 ASTHENIA 2 0.0000
103 HYPOTENSION 1 0.0000
104 ARTHRALGIA 2 0.0000
105 DEPRESSION 1 0.0000
106 INCORRECT DOSE ADMINISTERED 1 0.0000
107 DECREASED APPETITE 1 0.0000
108 ABDOMINAL PAIN 1 0.0000
109 FEELING ABNORMAL 1 0.0000
110 DYSPNOEA 2 0.0000
111 PRODUCT DOSE OMISSION ISSUE 1 0.0000
112 INJECTION SITE PAIN 1 0.0000
113 DIARRHOEA 2 0.0000
114 FATIGUE 2 0.0000
115 MALAISE 1 0.0000
116 VOMITING 1 0.0000
117 PAIN 1 0.0000
118 HEADACHE 1 0.0000
119 DRUG INEFFECTIVE 2 0.0000
120 NAUSEA 1 0.0000
121 DEATH 1 0.0000
122 OFF LABEL USE 1 0.0000